TG Therapeutics
TGTX
#2242
Rank
A$12.13 B
Marketcap
A$79.29
Share price
3.81%
Change (1 day)
45.52%
Change (1 year)

Earnings for TG Therapeutics (TGTX)

Earnings in 2026 (TTM): A$0.20 Billion

According to TG Therapeutics's latest financial reports the company's current earnings are A$0.79 Billion. In 2025 the company made an earning of A$0.19 Billion, an increase over its 2024 earnings that were of A$71.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for TG Therapeutics from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.20 B7.11%
2025 A$0.19 B169.57%
2024 A$71.24 M93.76%
2023 A$36.76 M-113.65%
2022 -A$0.27 Billion-45.06%
2021 -A$0.5 Billion25.42%
2020 -A$0.4 Billion62.93%
2019 -A$0.24 Billion-3.34%
2018 -A$0.25 Billion46.05%
2017 -A$0.17 Billion48.38%
2016 -A$0.12 Billion29.09%
2015 -A$88.75 Million12.99%
2014 -A$78.55 Million180.92%
2013 -A$27.97 Million
2009 -A$2.54 Million-59.85%
2008 -A$6.32 Million
2006 -A$14.33 Million-48.34%
2005 -A$27.72 Million215.12%
2004 -A$8.8 Million29.1%
2003 -A$6.82 Million159.59%
2002 -A$2.63 Million
2000 -A$4.51 Million12.38%
1999 -A$4.01 Million7.69%
1998 -A$3.73 Million-49.02%
1997 -A$7.31 Million82.14%
1996 -A$4.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Alkermes
ALKS
A$0.33 B 70.54%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Dr. Reddy's Laboratories
RDY
A$0.72 B 261.82%๐Ÿ‡ฎ๐Ÿ‡ณ India